Stocktwits on MSN10d
Black Diamond Therapeutics Shares Jump On New Partnership With France-Based Servier: Retail Sentiment Hits Year-High
Shares of Black Diamond Therapeutics, Inc. (BDTX) jumped around 21% as of Wednesday noon after the company announced it had ...
Black Diamond price target raised to $12 from $11 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on Black Diamond Therapeutics (BDTX) to $12 from $11 and keeps a Buy rating on the shares ...
4BDTX : Black Diamond Therapeutics Inks Licensing Pact With French Pharma...
Servier announces a strategic worldwide licensing agreement for Black Diamond Therapeutics' BDTX-4933 for solid tumors for an ...
Business Insider23d
Black Diamond Therapeutics price target lowered to $15 from $16 at Stifel
Stifel lowered the firm’s price target on Black Diamond Therapeutics (BDTX) to $15 from $16 and keeps a Buy rating on the shares. The firm updated its model for the quarter, including the cash ...